메뉴 건너뛰기




Volumn 21, Issue 3, 2014, Pages 125-133

Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study

Author keywords

FOLFOX4; Gastroesophageal junction cancer; Preoperative chemoradiotherapy

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

EID: 84902682619     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.1570     Document Type: Article
Times cited : (12)

References (36)
  • 3
    • 0033853456 scopus 로고    scopus 로고
    • Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries
    • Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645-54.
    • (2000) Int J Epidemiol , vol.29 , pp. 645-654
    • Botterweck, A.A.1    Schouten, L.J.2    Volovics, A.3    Dorant, E.4    van Den Brandt, P.A.5
  • 5
    • 0031784518 scopus 로고    scopus 로고
    • Classifcation of adenocarcinoma of the oesophagogastric junction
    • Siewert JR, Stein HJ. Classifcation of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 1457-9.
    • (1998) Br J Surg , vol.85 , pp. 1457-1459
    • Siewert, J.R.1    Stein, H.J.2
  • 6
    • 33846145078 scopus 로고    scopus 로고
    • Adenocarcinoma of the esophago-gastric junction
    • Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surgery 2006;95:260-9.
    • (2006) Scand J Surgery , vol.95 , pp. 260-269
    • Siewert, J.R.1    Stein, H.J.2    Feith, M.3
  • 7
    • 43449107054 scopus 로고    scopus 로고
    • Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: Results of the 2001 gastric patient care evaluation
    • Wilkinson NW, Howe J, Gay G, Patel Parekh L, Scott Conner C, Donohue J. Differences in the pattern of presentation and treatment of proximal and distal gastric cancer: results of the 2001 gastric patient care evaluation. Ann Surg Oncol 2008;15:1644-50.
    • (2008) Ann Surg Oncol , vol.15 , pp. 1644-1650
    • Wilkinson, N.W.1    Howe, J.2    Gay, G.3    Patel Parekh, L.4    Scott Conner, C.5    Donohue, J.6
  • 8
    • 33845410539 scopus 로고    scopus 로고
    • Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist
    • Griffths EA, Pritchard SA, Mapstone NP, Welch IM. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist. World J Surg Oncol 2006;4:82.
    • (2006) World J Surg Oncol , vol.4 , pp. 82
    • Griffths, E.A.1    Pritchard, S.A.2    Mapstone, N.P.3    Welch, I.M.4
  • 9
    • 0035142280 scopus 로고    scopus 로고
    • The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction
    • Dresner SM, Lamb PJ, Bennet MK, Hayes N, Griffn SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103-9.
    • (2001) Surgery , vol.129 , pp. 103-109
    • Dresner, S.M.1    Lamb, P.J.2    Bennet, M.K.3    Hayes, N.4    Griffn, S.M.5
  • 10
    • 0037156943 scopus 로고    scopus 로고
    • The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction
    • Wajman J, Bennett MK, Raimes SA, Griffn SM. The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction. Br J Cancer 2002; 86:1223-9.
    • (2002) Br J Cancer , vol.86 , pp. 1223-1229
    • Wajman, J.1    Bennett, M.K.2    Raimes, S.A.3    Griffn, S.M.4
  • 11
    • 80055102981 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer. Do we need another randomized trial?
    • Hingorani M, Crosby T, Maraveyas A, Dixit S, Bateman A, Roy R. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer. Do we need another randomized trial? Clin Oncol (R Coll Radiol) 2011;23:696-705.
    • (2011) Clin Oncol (R Coll Radiol , vol.23 , pp. 696-705
    • Hingorani, M.1    Crosby, T.2    Maraveyas, A.3    Dixit, S.4    Bateman, A.5    Roy, R.6
  • 12
    • 60849118127 scopus 로고    scopus 로고
    • Phase iii comparison of preoperative chemotherapy compared with chemoradio-therapy in patients with locally advanced adenocarcinoma of the esophagogastric junction
    • Stahl M, Walz MK, Stuschke M, et al. Phase iii comparison of preoperative chemotherapy compared with chemoradio-therapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851-6.
    • (2009) J Clin Oncol , vol.27 , pp. 851-856
    • Stahl, M.1    Walz, M.K.2    Stuschke, M.3
  • 13
    • 77951084425 scopus 로고    scopus 로고
    • Adjuvant chemoradio-therapy in patients with stage iii or iv radically resected gastric cancer: A pilot study
    • Orditura M, De Vita F, Muto P, et al. Adjuvant chemoradio-therapy in patients with stage iii or iv radically resected gastric cancer: a pilot study. Arch Surg 2010;145:233-8.
    • (2010) Arch Surg , vol.145 , pp. 233-238
    • Orditura, M.1    de Vita, F.2    Muto, P.3
  • 15
    • 0003575141 scopus 로고    scopus 로고
    • United States, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program (ctep, Bethesda, MD: ctep, cited May 12, 2011
    • United States, Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Cancer Therapy Evaluation Program (ctep). Common Toxicity Criteria (CTC). Ver. 2.0. Bethesda, MD: ctep; 1999. [Available online at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcv20_4-30-992.pdf; cited May 12, 2011]
    • (1999) Common Toxicity Criteria (CTC). Ver. 2.0
  • 16
    • 0028969271 scopus 로고
    • Toxicity criteria of the Radiation Therapy Oncology Group (rtog) and the European Organiza-tion for Research and Treatment of Cancer (eortc)
    • Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (rtog) and the European Organiza-tion for Research and Treatment of Cancer (eortc). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , pp. 1341-1346
    • Cox, J.D.1    Stetz, J.2    Pajak, T.F.3
  • 17
    • 79959373978 scopus 로고    scopus 로고
    • Japanese gastric cancer t reatment guidelines 2010 (ver. 3)
    • Japanese Gastric Cancer Association
    • Japanese Gastric Cancer Association. Japanese gastric cancer t reatment guidelines 2010 (ver. 3). Gastric Cancer 2011; 14: 113-23.
    • (2011) Gastric Cancer , vol.14 , pp. 113-123
  • 18
    • 84861875920 scopus 로고    scopus 로고
    • Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: A meta-analysis
    • Yang K, Chen HN, Chen XZ, et al. Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One 2012;7:e37698.
    • (2012) PLoS One , vol.7
    • Yang, K.1    Chen, H.N.2    Chen, X.Z.3
  • 19
    • 0028305674 scopus 로고
    • Pathologic assessment of tumor regression after preoperative chemora-diotherapy of esophageal carcinoma
    • Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemora-diotherapy of esophageal carcinoma. Cancer 1994;73:2680-6.
    • (1994) Cancer , vol.73 , pp. 2680-2686
    • Mandard, A.M.1    Dalibard, F.2    Mandard, J.C.3
  • 20
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 21
    • 3042668007 scopus 로고    scopus 로고
    • Biostatistics 203. Survival analysis
    • Chan YH. Biostatistics 203. Survival analysis. Singapore Med J 2004;45: 249-56.
    • (2004) Singapore Med J , vol.45 , pp. 249-256
    • Chan, Y.H.1
  • 23
    • 41949119177 scopus 로고    scopus 로고
    • Phase iii trial of trimodality therapy with cisplatin, fuorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer. calgb 9781
    • Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase iii trial of trimodality therapy with cisplatin, fuorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer. calgb 9781. J Clin Oncol 2008;26:1086-92.
    • (2008) J Clin Oncol , vol.26 , pp. 1086-1092
    • Tepper, J.1    Krasna, M.J.2    Niedzwiecki, D.3
  • 24
    • 0035863382 scopus 로고    scopus 로고
    • Randomized trial of preoperative chemo-radiation versus surgery alone in patients with locoregional esophageal carcinoma
    • Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemo-radiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-13.
    • (2001) J Clin Oncol , vol.19 , pp. 305-313
    • Urba, S.G.1    Orringer, M.B.2    Turrisi, A.3    Iannettoni, M.4    Forastiere, A.5    Strawderman, M.6
  • 25
    • 24044509153 scopus 로고    scopus 로고
    • Su rger y alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase iii trial
    • Burmeister BH, Smithers BM, Gebski V, et al. Su rger y alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase iii trial. Lancet Oncol 2005;6:659-68.
    • (2005) Lancet Oncol , vol.6 , pp. 659-668
    • Burmeister, B.H.1    Smithers, B.M.2    Gebski, V.3
  • 26
    • 3042584502 scopus 로고    scopus 로고
    • Preoperative chemora-diotherapy for oesophageal cancer: A systematic review and meta-analysis
    • Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemora-diotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004;53:925-30.
    • (2004) Gut , vol.53 , pp. 925-930
    • Fiorica, F.1    Di Bona, D.2    Schepis, F.3
  • 27
    • 33747763374 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy
    • Reynolds JV, Ravi N, Hollywood D, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2006;132:549-55.
    • (2006) J Thorac Cardiovasc Surg , vol.132 , pp. 549-555
    • Reynolds, J.V.1    Ravi, N.2    Hollywood, D.3
  • 28
    • 84861679981 scopus 로고    scopus 로고
    • Preopera-tive chemoradiotherapy for esophageal or junctional cancer
    • Van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preopera-tive chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366:2074-84.
    • (2012) N Engl J Med , vol.366 , pp. 2074-2084
    • van Hagen, P.1    Hulshof, M.C.2    van Lanschot, J.J.3
  • 29
    • 84857557133 scopus 로고    scopus 로고
    • Phase ii trial of pre-operative chemoradiotherapy with oxaliplatin, cisplatin, and 5-fu in locally advanced esophageal and gastric cancer
    • Pera M, Gallego R, Montagut C, et al. Phase ii trial of pre-operative chemoradiotherapy with oxaliplatin, cisplatin, and 5-fu in locally advanced esophageal and gastric cancer. Ann Oncol 2012;23:664-70.
    • (2012) Ann Oncol , vol.23 , pp. 664-670
    • Pera, M.1    Gallego, R.2    Montagut, C.3
  • 30
    • 84872811742 scopus 로고    scopus 로고
    • Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxali-platin in patients with locally advanced esophageal cancer
    • Wahba HA, El-Hadaad HA, Abd-Ellatif EA. Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxali-platin in patients with locally advanced esophageal cancer. Med Oncol 2012;29:1693-8.
    • (2012) Med Oncol , vol.29 , pp. 1693-1698
    • Wahba, H.A.1    El-Hadaad, H.A.2    Abd-Ellatif, E.A.3
  • 31
    • 63949084961 scopus 로고    scopus 로고
    • Multi-center phase ii trial of chemo-radiotherapy with 5-fuorouracil, leu-covorin and oxaliplatin in locally advanced esophageal cancer
    • Chiarion-Sileni V, Innocente R, Cavina R, et al. Multi-center phase ii trial of chemo-radiotherapy with 5-fuorouracil, leu-covorin and oxaliplatin in locally advanced esophageal cancer. Cancer Chemother Pharmacol 2009; 63: 1111-19.
    • (2009) Cancer Chemother Pharmacol , vol.63 , pp. 1111-1119
    • Chiarion-Sileni, V.1    Innocente, R.2    Cavina, R.3
  • 32
    • 79551583770 scopus 로고    scopus 로고
    • A multicenter phase ii study of induction chemotherapy with folfox-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer
    • De Vita F, Orditura M, Martinelli E, et al. A multicenter phase ii study of induction chemotherapy with folfox-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer. Br J Cancer 2011;10 4:427-32.
    • (2011) Br J Cancer , vol.10 , Issue.4 , pp. 427-432
    • de Vita, F.1    Orditura, M.2    Martinelli, E.3
  • 33
    • 71649083039 scopus 로고    scopus 로고
    • Phase ii trial of preop-erative irinotecan-cisplatin followed by concurrent irinote-can-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma
    • Rivera F, Galan M, Tabernero J, et al. Phase ii trial of preop-erative irinotecan-cisplatin followed by concurrent irinote-can-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. Int J Radiat Oncol Biol Phys 2009: 75:1430-6.
    • (2009) Int J Radiat Oncol Biol Phys , vol.75 , pp. 1430-1436
    • Rivera, F.1    Galan, M.2    Tabernero, J.3
  • 34
    • 33748462703 scopus 로고    scopus 로고
    • Phase ii trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (rtog 9904): Quality of combined modality therapy and pathological response
    • Ajani JA, Winter K, Okawara GS, et al. Phase ii trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (rtog 9904): quality of combined modality therapy and pathological response. J Clin Oncol 2006;24:3953-8.
    • (2006) J Clin Oncol , vol.24 , pp. 3953-3958
    • Ajani, J.A.1    Winter, K.2    Okawara, G.S.3
  • 35
    • 77956636233 scopus 로고    scopus 로고
    • Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esopha-geal cancer: A phase ii study
    • Orditura M, Galizia G, Napolitano V, et al. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esopha-geal cancer: a phase ii study. Cancer Invest 2010; 28:820-7.
    • (2010) Cancer Invest , vol.28 , pp. 820-827
    • Orditura, M.1    Galizia, G.2    Napolitano, V.3
  • 36
    • 79955576900 scopus 로고    scopus 로고
    • Perioperative chemotherapy compared with surgery alone for resectable gastro-esophageal adenocarcinoma: An fnclcc and ffcd multicenter phase iii trial
    • Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastro-esophageal adenocarcinoma: an fnclcc and ffcd multicenter phase iii trial. J Clin Oncol 2011; 29: 1715-21.
    • (2011) J Clin Oncol , vol.29 , pp. 1715-1721
    • Ychou, M.1    Boige, V.2    Pignon, J.P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.